• This field is for validation purposes and should be left unchanged.

Verdi Oncology Announces Appointment of Two New Members to the Senior Leadership Team

September 19, 2022

BRENTWOOD, TN — September 19, 2022 — Verdi Oncology, a leading practice management and services company focused on expanding community-based oncology, appointed two new members to the company’s leadership team. Bob Wiemer, Senior Vice President of Strategic Growth, is responsible for driving growth initiatives in high-potential markets. Brandi Scelsi, Vice President of Clinical Operations, is responsible for providing strategic oversight of clinical teams within the Verdi Network.

“We have a tremendous opportunity to expand our network into new regions while also increasing access to world-class clinical trials. We are thrilled to have Bob and Brandi join our leadership team,” said Bill Herman, CEO of Verdi Oncology. “Together, they bring extensive clinical and operational experience and perfectly align with our mission of providing access to high-quality, innovative oncology care.”

Bob Wiemer is a senior healthcare executive with over 25 years of experience within B2B SaaS products, professional staffing services, and healthcare operating companies. During his career, he has had a full scope of P&L, finance, HR, product development, sales, marketing, and operations management. He has a track record of being a growth-oriented problem solver who drives results.

“I am honored to join Verdi Oncology and energized by the ample opportunity to expand the Verdi Network into new markets,” said Bob Wiemer, Senior Vice President of Strategic Growth.

Brandi Scelsi, MBA, RN, is a healthcare professional with over 20 years of experience in practice and leadership roles related to critical care, quality improvement, and program development in the areas of cancer, cardiology, and pediatrics. Her relentless passion for the patients and teams she serves is punctuated by a deep understanding of data processes and proven success in solving complex problems with kindness, compassion, and objectivity.

“Verdi is committed to advancing oncology through cutting-edge clinical research. I couldn’t be more thrilled to join in that endeavor,” said Brandi Scelsi, Vice President of Clinical Operations. “Sharing my gifts and talents to help others brings me great joy.”

About Verdi Oncology, Inc.

Verdi Oncology is an oncology practice management and services company headquartered in Brentwood, TN. Verdi is firmly rooted in the belief that community-based oncology is the best way to expand patient access to high-quality, innovative care. Verdi is supported by Pharos Capital — a physician-founded, healthcare-focused, private equity investor.  For over 21 years, Pharos has invested over $1 billion in companies that improve the patient care experience, reduce total care costs, and increase access to such value care.